Mixed Markets Ahead Of Earnings

On the upside

The Food and Drug Administration informed MAP Pharmaceuticals (Nasdaq: MAPP) that another effectiveness study of its migraine treatment Levadex would not be necessary.

AMAG Pharmaceuticals (NYSE: AMAG) reported better than expected sales of its anemia treatment Feraheme.

Ford (NYSE: F) won both the North American Car as well as Truck of the Year award at the 2010 North American International Auto Show.

On the downside

Zhongpin (Nasdaq: HOGS) disappointed with a 2010 full year forecast that missed estimates.

InterOil (Nasdaq: IOC) reported that a second test at its Antelope-2 well in Papua New Guinea confirmed a higher stabilized condensate to gas ratio.

Nu Skin (NYSE: NUS) named Stuart Kim, Ph.D. to its Nu Skin Anti-Aging Scientific Advisory Board.

In the broad market, advancing issues outpaced decliners by a margin of more than 9 to 7 on the NYSE while decliners edged out advancers by nearly 10 to 9 on Nasdaq. The Russell 2000 which tracks small cap stocks lost 2 points to 642.